Bioregulators Peptides
Short peptide bioregulators (Khavinson peptides) researched for organ-specific support.
About Bioregulators Peptides
Bioregulator peptides are ultra-short peptides (typically 2-4 amino acids) developed primarily by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. Each bioregulator is designed to target specific organs or tissues, theoretically supporting optimal gene expression and cellular function. Examples include Epithalon (pineal gland), Thymalin (thymus), Vilon (immune), and many organ-specific variants. These peptides represent a unique approach to supporting healthy aging through tissue-specific interventions.
All Bioregulators Peptides (16)
Epithalon
Clinical TrialsAlso: Epitalon, Epithalone
A tetrapeptide studied for its effects on telomerase activation and potential anti-aging properties. Based on research by Professor Vladimir Khavinson.
Thymalin
Clinical TrialsAlso: Thymic Factor, Thymus Extract
A thymic peptide complex used in Russia for immune enhancement and anti-aging. Part of Professor Khavinson's bioregulator peptide research.
Pinealon
PreclinicalAlso: EDR, Glu-Asp-Arg
A synthetic tripeptide bioregulator targeting brain tissue. Part of Khavinson's peptide research, designed to support cognitive function and neuroprotection.
Vilon
PreclinicalAlso: Lys-Glu, KE Dipeptide
A synthetic dipeptide bioregulator targeting thymic function. Part of Khavinson's peptide bioregulator research for immune and anti-aging effects.
Cartalax
PreclinicalAlso: Ala-Glu-Asp, AED Tripeptide
A synthetic tripeptide bioregulator targeting cartilage tissue. Developed for joint health and cartilage regeneration.
Livagen
PreclinicalAlso: Lys-Glu-Asp-Ala, KEDA
A tetrapeptide bioregulator (Lys-Glu-Asp-Ala) developed by Khavinson that modulates chromatin structure and gene expression. Research shows it can decondense heterochromatin and activate ribosomal genes, potentially restoring more youthful gene expression patterns in aging cells.
Ovagen
PreclinicalAlso: Glu-Asp-Leu, EDL
A tripeptide bioregulator (Glu-Asp-Leu) targeting liver and gastrointestinal tissue. Derived from liver tissue extracts, Ovagen modulates gene expression related to detoxification, antioxidant defense, and hepatocellular repair.
Cortagen
PreclinicalAlso: Ala-Glu-Asp-Pro, AEDP
A tetrapeptide bioregulator (Ala-Glu-Asp-Pro) derived from cerebral cortex extracts. Studied for neuroprotection, neural differentiation, and cognitive support. Regulates neurotrophic signaling and synaptic stability.
Vesugen
PreclinicalAlso: Lys-Glu-Asp, KED
A tripeptide bioregulator (Lys-Glu-Asp) targeting vascular tissue. Promotes restoration of blood vessel tissues and normalization of vascular function. Stimulates endothelial cell proliferation markers.
Chonluten
PreclinicalAlso: Glu-Asp-Gly, EDG
A tripeptide bioregulator targeting respiratory and lung tissue. Supports healthy lung function and stomach lining. Regulates inflammatory and proliferative processes in respiratory epithelium.
Crystagen
PreclinicalAlso: Glu-Asp-Pro, EDP
A tripeptide bioregulator supporting immune system function. Demonstrates age-associated immunoprotective properties in spleen tissue. Part of the Khavinson synthesized peptide series.
Prostamax
PreclinicalA peptide bioregulator targeting prostate tissue. One of five highly efficient synthesized peptides developed by Khavinson with demonstrated effects on gene expression and tissue-specific regulation.
Testagen
PreclinicalA peptide bioregulator targeting testicular tissue. Supports healthy testicular function through tissue-specific gene regulation. Part of the Khavinson peptide bioregulator family.
Thyreogen
PreclinicalA peptide bioregulator derived from thyroid tissue. Regulates thyroid function and metabolism. Contains peptide complex with glutamic acid, aspartic acid, tyrosine, phenylalanine, proline, and serine.
Ventfort
PreclinicalA peptide bioregulator targeting vascular tissue and blood vessels. Derived from blood vessel extracts, it supports healthy vascular function and vessel wall integrity. Part of the Khavinson bioregulator family.
Veslugen
PreclinicalA peptide bioregulator targeting vascular and circulatory system. Supports healthy blood vessel function and circulation. Part of the Khavinson synthesized peptide bioregulator family.
Frequently Asked Questions About Bioregulators Peptides
What are bioregulator peptides?
Bioregulator peptides are very short peptides (2-4 amino acids) developed by Russian scientist Vladimir Khavinson. They're designed to target specific organs and tissues, theoretically helping restore optimal gene expression patterns that may decline with age.
How do bioregulators work?
Bioregulators are theorized to work by interacting with DNA and influencing gene expression in specific tissues. Each bioregulator has an affinity for particular organs, potentially supporting cellular function and protein synthesis in those tissues.
Are bioregulators proven to work?
Bioregulators have been researched primarily in Russia with some published studies showing benefits. However, they lack FDA approval and extensive Western clinical trials. More research is needed to fully validate their mechanisms and efficacy.
Explore Other Categories
Educational Information Only
This information about bioregulators peptides is for educational purposes only and does not constitute medical advice. Always consult qualified healthcare providers before making decisions about peptides or supplements.